首页|期刊导航|世界中医药杂志（英文版）|Network Meta-analysis of Four Chinese Patent Medicines Combined with Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Early Diabetic Nephropathy Treatment
世界中医药杂志（英文版）2020，Vol.6Issue(1)：51-60,10.
Network Meta-analysis of Four Chinese Patent Medicines Combined with Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Early Diabetic Nephropathy Treatment
Network Meta-analysis of Four Chinese Patent Medicines Combined with Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Early Diabetic Nephropathy Treatment
摘要
关键词
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/Chinese patent medicine/drug combination/early diabetic nephropathy/network meta-analysisKey words
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/Chinese patent medicine/drug combination/early diabetic nephropathy/network meta-analysis引用本文复制引用
Jing Zhang,Jing Li,Jia-Qin Huang..Network Meta-analysis of Four Chinese Patent Medicines Combined with Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Early Diabetic Nephropathy Treatment[J].世界中医药杂志（英文版）,2020,6(1):51-60,10.基金项目
This study was supported by the National Natural Science Foundation Project of China (youth science fund project 81603570). （youth science fund project 81603570）
